Loading…
Based on limited metadata without access to the full warning letter text, the FDA issued a warning to Soleo on December 13, 2018, regarding drug products. While the specific subject matter and detailed violations are not available in the metadata provided, this appears to be a drug manufacturing or distribution compliance issue under FDA oversight. The warning indicates potential regulatory concerns related to drug safety, quality, or manufacturing standards, though the precise nature of the violations cannot be determined from the metadata alone.